Gender, Sex Hormones, and Secretagogues Influence Growth Hormone Recovery in Older Adults
Background
Growth hormone (GH) is a crucial peptide hormone involved in metabolism, body composition, and overall well-being. As individuals age, GH levels naturally decline, a phenomenon known as somatopause, which can contribute to age-related health issues. The body's intricate feedback mechanisms tightly regulate GH secretion, but how these mechanisms recover after suppression, particularly in older populations, is not fully understood. This study addresses how gender, sex-steroid hormones, and specific GH secretagogues affect the recovery of endogenous GH secretion after exogenous GH-induced feedback in older men and women.
Results
The study revealed significant gender-specific differences in the recovery of growth hormone secretion. Women demonstrated significantly faster recovery of GH pulse amplitude, achieving 75% of their baseline levels by 6 hours post-secretagogue, compared to men who reached only 45% by the same time (p<0.001). Estrogen levels in women positively correlated with the rate of GH recovery (r=0.72, p<0.005), with women in the highest estrogen quartile showing a 2.1-fold faster recovery. Conversely, in men, higher free testosterone levels were associated with a 1.8-fold slower recovery of GH pulse frequency (p<0.01). Furthermore, GHRH administration resulted in a 35% higher peak GH response compared to GHRP-2 in older men (p<0.001), while in women, the difference was only 10% and not statistically significant. > Women exhibit a more robust and rapid recovery of endogenous growth hormone secretion following exogenous suppression compared to men, with sex-steroid levels playing a critical modulatory role.
Why It Matters
Understanding these gender- and hormone-specific differences in growth hormone regulation is crucial for addressing age-related decline in GH, known as somatopause. This research highlights the importance of considering individual biological factors when designing interventions for GH deficiency. The findings underscore the potential for personalized medicine approaches in optimizing GH replacement therapies or other interventions aimed at improving metabolic health and body composition in older adults. This knowledge could lead to new strategies for tailoring GH-modulating therapies based on an individual's gender and sex-steroid profile, potentially improving efficacy and reducing side effects in future clinical applications.